Introduction {#sec1-1}
============

Obesity is a chronic inflammatory state characterised by elevated pro-inflammatory adipokines \[[@ref1]\]. Adipose tissue in obese subjects is characterised by increased macrophages infiltration, which is thought to play a role in the pathogenesis of pro-inflammatory events \[[@ref2]\]. Resistin is one of the pro-inflammatory adipokines and has been associated with obesity. The expression of resistin increases with adipose differentiation \[[@ref3]\]. Resistin plays an important role in regulating energy, glucose and fat homeostasis by modulating hepatic insulin action with single nucleotide polymorphisms (SNPs) \[[@ref4]\].

Two-thirds of plasma resistin variations are influenced by genetics \[[@ref5]\]. Resistin gene is on the 19p3.2 chromosome, consists of 4 exons and 3 introns. This gene is polymorphic in SNPs of promoters, introns and 3'UTR. The SNP promoter -420C/G (rs1862513) is associated with obesity \[[@ref6]\], insulin sensitivity and resistance, elevated blood sugar levels and lipid profile \[[@ref7]\], \[[@ref8]\]. However, results from some studies in various populations did not show any association of lipid profiles \[[@ref5]\] and obesity \[[@ref3]\]. The effect of SNP -420C \> G on its expression was estimated due to its effect on the binding of a transcription factor on RETN promoter \[[@ref8]\]. Research on the +299 *RETN* gene polymorphism showed +299G \> A polymorphism was significantly associated with elevated plasma resistin \[[@ref9]\]. Polymorphism of +299G \> A *RETN* gene in a cohort study showed that A allele is associated with increased risk of Metabolic Syndrome \[[@ref10]\], but in a study of Iranian patients with Gestational Diabetes Mellitus, this allele was not significantly different with controls \[[@ref11]\].

This study aimed to correlate the polymorphisms of +299G \> A (rs3745367) and -420C \> G (rs1862513) *RETN* gene in obese Indonesian population with levels of resistin and insulin resistance.

Methods {#sec1-2}
=======

This research was a case-control study involving 142 healthy participants 18-40 years old, consisting of 71 subjects with Body Mass Index (BMI) ≥ 25 kg/m^2^ as the obese group and 71 subjects with BMI 18.50 to 23 Kg/m^2^ as the control group. Samples were taken with consecutive sampling.

All subjects had normal blood glucose concentrations. Subjects who consumed anti-diabetes and anti-inflammatory drugs were excluded from this research. All subjects agreed to participate and signed an informed consent form. This study was by the Helsinki Declaration and had approval from the Medical and Health Research Ethics Committee of the Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia, number: KE/FK/569/EC/2015.

Samples {#sec2-1}
-------

Blood was drawn from subjects after fasting 8 hours, and the plasma was separated from buffy coat. Fasting blood glucose, insulin and resistin levels were measured from plasma. DNA was isolated from buffy coat for determination of *RETN* polymorphism. Blood glucose was determined by the enzymatic method with the Dyasis kit. Resistin and insulin levels were measured with Elisa kit (Elabscience catalogue number: E-EL-H1213). Determination of insulin resistance was calculated by the following formula:

HOMA-IR = {insulin (µU/mL) X glucose (mmol/L)}/22.5

HOMA-IR \> 2.0 was grouped as glucose intolerance \[[@ref12]\].

Isolation of DNA was done with Promega kit, and genotyping of resistin genes was examined with the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) methods.

Genotyping of +299G \> A RETN gene {#sec2-2}
----------------------------------

DNA was amplified with forwarding primer 5'GAGAGGATCCAGGAGGTCG 3' and reverse primer 5'GTGAGACCAAACGGTCCCT 3'. The PCR was done as follows:

Denaturation at 95°C for 5 min, pre-annealing at 59°C 1 min, elongation at 72°C for 2 min, then 35 cycles of 30 s at 95°C, 30 s at 59°C and 1 min 15 s at 72°C, and elongation at 72°C for 10 min. Product of PCR was 373 base pair (bp) then digested by AluI enzymes (MBI-Fermentas, United Kingdom) and separated by electrophoresis with 2% agarose gel and stained with ethidium bromide \[[@ref13]\].

Genotyping of -420G \> C RETN gene {#sec2-3}
----------------------------------

DNA was amplified with forwarding primer 5'- TGTCATTCTCACCCAGAGACA-3' and reversed primer 5'-TGGGCTCAGCTAACCAAATC-3'. The PCR method was as follows: denaturation at 95°C for 7 min, pre-annealing at 61°C for 1 min, elongation at 72°C for 2 min followed by 35 cycles of 30 s at 95°C, 30 s at 64°C and for 1 min 15 s at 72 °C and final elongation for 10 min at 72°C. The 534 bp PCR products were digested with BbsI enzyme at 37°C for 16 hours. The digestion products were separated by electrophoresis with 2% agarose gel. The G allele was visualised at 327 bp and C allele at 207 bp \[[@ref14]\].

Statistical Analysis {#sec2-4}
--------------------

All statistical analyses were performed using SPSS 17 software. Variables that were not normally distributed were presented as mean with Interquartile Range (IQR). The associations of +299 G \> A and -420 C \> G *RETN* with resistin level were analysed with the Kruskal Wallis test. The associations of +299G \> A and -420C \> G *RETN* with insulin resistance were analysed with logistic regression. Serum resistin level associated with BMI and insulin resistance parameters were analysed with simple linear regression, and the results were considered significantly different when *p* \< 0.05.

Results {#sec1-3}
=======

Characteristics of subjects {#sec2-5}
---------------------------

The BMI, insulin level and HOMA-IR in the obese group were higher and significantly different compared with the control group (*p* \< 0.05) ([Table 1](#T1){ref-type="table"}).

###### 

Characteristic of subjects

  Variable           Obese (n = 71)         Control (n = 71)        *P*
  ------------------ ---------------------- ----------------------- -----------
  Sex                                                               
   Male              30 (42.3%)             25 (35.2%)              0.389
   Female            41 (57.7%)             46 (64.8%)              
  Age (Year)         25.8 ± 5.9             25.4 ± 5.7              0.545
  BMI (kg/m^2^)      31.9 ± 4.02            20.86 ± 1.66            \< 0.0001
  FBG (mg/dL)        89.10 ± 1.23           88.55 ± 1.15            0.830
  Insulin (mU/L)     17.74 ± 1.88           11.27 ± 1.88            \< 0.0001
  HOMA-IR            3.90 ± 2.04            1.46 ± 1.26             \< 0.0001
  Resistin (pg/mL)   310.1 (1.07-1645.89)   313.35 (1.10-1835.99)   0.375

BMI: Body Mass Index; FBG: Fasting Blood Glucose; HOMA-IR: Homeostatic Model Assessment-Insulin Resistance. Data were presented as the mean ± standard deviation for normally distributed data. Data were presented as median (minimum-maximum) for the data not normally distributed.

The polymorphism of +299G \> A *RETN* gene, frequency of GG, GA and AA genotypes were not significantly different (*p* = 0.429) and G allele compared to A allele between obese and control groups were not significantly different (*p* = 0.719). The frequency of CC genotype compared with other types (CG and GG) of -420 C \> G *RETN* gene were not significantly different (*p* = 0.583) and C allele compared to G allele in obese, and control groups were not significantly different (*p* = 0.905) ([Figure 1](#F1){ref-type="fig"}).

![Frequency of +299G \> A and -420C \> G genotypes and allele RETN gene in obese and control groups](OAMJMS-7-1891-g001){#F1}

The association of resistin level with +299G \> A and -420C \> G *RETN* gene showed there were no significant differences in the obese and control groups ([Table 2](#T2){ref-type="table"}).

###### 

Level of Resistin in +299G\>A and -420C\>G *RETN* genotype in obese and control groups

                                       Resistin level (pg/mL)                      *P*
  ------------------ ----------------- ------------------------ ------------------ -------
  +299G \> A         GG                GA                       AA                 
  Obese (n = 71)     239.53 (390.47)   337.52 (555.75)          522.59 (1079.84)   0.390
  Control (n = 71)   438.51 (292.55)   310.10 (562.05)          165.52 (370.21)    0.339
  -420C \> G         CC                CG                       GG                 
  Obese (n = 71)     168.42 (708.32)   310.10 (2508.71)         310.45 (224.52)    0.722
  Control (n = 71)   376.27 (373.33)   336.62 (498.96)          82.89 (149.44)     0.224

Data presented as median (IQR) because the data was not normally distributed.

The association between polymorphism of +299G \> A and -420C \> G *RETN* gene with insulin resistance showed GA genotypes compared with GG genotype were correlated with insulin resistance *(p \<* 0.001), as well as GA+AA genotype, was correlated with insulin resistance (*p* \< 0.001). Polymorphism of -420C \> G *RETN* gene, however, was not correlated with insulin resistance (*p* \> 0.05) ([Table 3](#T3){ref-type="table"}).

###### 

Association of +299G\>A and -420C/G polymorphism of the *RETN* gene with insulin resistance

  +299 *RETN gene* (GG compared with GA, AA and GA+AA)   Coefficient   Odds Ratio   95% CI for OR    *P*
  ------------------------------------------------------ ------------- ------------ ---------------- ----------
  GA                                                     1.68          5.375        (2.20 - 13.13)   \< 0.001
  AA                                                     2.13          8.437        (0.95 - 74.85)   0.055
  GA + AA                                                1.72          5.566        (2.31 - 13.44)   \< 0.001
                                                                                                     
  -420 *RETN* gene (CC compared with CG, GG and CG+GG)                                               
                                                                                                     
  CG                                                     -0.43         0.649        (0.20, 2.09)     0.470
  GG                                                     -0.86         0.424        (0.10, 1.78)     0.240
  CG + GG                                                -0.51         0.599        (0.19, 1.89)     0.383

Serum resistin levels were significantly associated with insulin level with simple linear regression and had negative coefficient (*p =* 0.017), which indicated there were increases of resistin levels that were correlated with decreases of insulin level ([Tables 4](#T4){ref-type="table"}).

###### 

Simple linear regression of the variables with resistin level

  Variable        Coefficient   95% CI                *P*     R^2^
  --------------- ------------- --------------------- ------- -------
  BMI             2.24          (-8.84) -- (13.32)    0.721   0.001
  Blood glucose   2.05          (-2.24) -- (6.33)     0.342   0.007
  INSULIN         -6.33         (-11.44) -- (-1.16)   0.017   0.040
  HOMA-IR         -19.13        (-39.94) - (1.69)     0.075   0.023

Discussion {#sec1-4}
==========

The results of this study show there were significant differences in the levels of insulin and HOMA-IR between obese compared with the controls. The polymorphism of +299G \> A *RETN* gene was correlated with insulin resistance but not for the -420C \> G *RETN* gene. In the association of resistin level to insulin level and insulin resistance, we found serum resistin levels were significantly correlated with insulin level but for HOMA-IR index.

HOMA-IR index in the obese group was higher than the control group like findings in some studies \[[@ref5],[@ref15]\]. Resistin level between obese and control groups in this study did not differ significantly. This is in line with a study by Savage et al., found no relationship between adiposity and resistin mRNA expression in freshly adipocytes subjects with ranging BMI from 22 -- 59 kg/m^2^ and insulin resistance \[[@ref16]\]. Resistin gene in humans is on chromosome 19p13.3 in an area that is not related to the vulnerability of obesity and insulin resistance \[[@ref17]\].

One study by Kuminski \[[@ref18]\] found expression of mRNA was not directly associated with expression of the protein, which, when modified both in the post-transcriptional and post-translational process can influence resistin levels. The relationship between the expression and secretion of resistin and other inflammatory markers, including IL-6, C- reactive protein (CRP) were reported in patients with severe inflammatory diseases. Mild inflammation due to obesity will interfere with the level of resistin \[[@ref19]\]. The differences of this result with others are probably due to differences in obesity grouping \[[@ref20]\]. Additionally, differences in the environmental factors may be affecting the HOMA-IR index. Polymorphism of +299G \> A was associated with insulin resistance showing GA and GA+AA genotypes were risk factors for insulin resistance compared with GG genotype, but the polymorphism of -420C \> G genotype was not a risk factor for insulin resistance.

This finding was different from studies in Korea \[[@ref21]\] and Thailand which showed no association between polymorphisms of +299G \> A and -420C \> G RETN gene with the parameters of the metabolic syndrome \[[@ref8]\]. A Lebanon population showed +299G \> A polymorphism was not involved in the pathogenesis of obesity and diabetes mellitus \[[@ref17]\]. Research in Japan and Egypt indicated polymorphism of -420C \> G *RETN* gene was associated with obesity \[[@ref22]\], \[[@ref23]\]. The differences in some of these studies may be because there were differences in ethnicity that cause unequal frequency in each population.

Polymorphism of +299G \> A and -420C \> G *RETN* gene in this study was not associated with levels of resistin and is in line with research in China \[[@ref24]\]. This result is in contrast with other studies showing this polymorphism is associated with increased levels of resistin in some East Asian populations, including Japanese, Korean, and Chinese, although data from the Caucasian population shows that this polymorphism is not associated with higher levels of resistin \[[@ref1]\]. *RETN* polymorphism is correlated to increased BMI, blood pressure, fasting blood glucose, HOMA-IR, triglycerides, total cholesterol, resistin level, and decreased in HDL-cholesterol \[[@ref5]\].

The results of research in non-obese type 2 diabetes mellitus patients showed the polymorphism of AA/AG genotypes of +299G \> A *RETN* gene is considered as a risk factor for increased insulin resistance, based on fasting blood glucose and HOMA-IR index \[[@ref13]\]. These results demonstrate ethnicity as a factor underlying the differences of SNPs in the influencing of human resistin expression \[[@ref19]\]. In this study, polymorphism of +299G \> A *RETN* gene was associated with insulin resistance. This result is similar to research in Iraq which showed that polymorphism *RETN* +299G \> A gene plays a role in insulin resistance \[[@ref25]\] and this polymorphism was found to increase the risk of diabetes mellitus in a population in Thailand \[[@ref8]\]. Polymorphism of -420C \> G *RETN* gene in this study was not associated with insulin resistance. This result is similar to a study in the Han population of China showing polymorphism of the *RETN* gene is not a risk factor for diabetes mellitus \[[@ref26]\]. A study by Wen \[[@ref27]\] in China reported the opposite results, finding this polymorphism increases the risk of diabetes mellitus.

Obesity is a polygenic effect that is influenced by a combination of several genes and environmental factors. Frequency of *RETN* gene varies with ethnicity and environment. Exposure to different environments such as dietary habits and genetic background other than differences in study design may cause different effects on obesity \[[@ref5]\]. These differences probably cause the different results in studies concerning the influence of the polymorphism of the *RETN* gene in the pathogenesis of obesity along with the small number of samples that might contribute to differences in results. Additional research is needed to identify factors associated with inflammation due to obesity and the correlation of resistin levels with polymorphisms of genes should be further investigated.

In conclusion, polymorphism of +299G \> A of *RETN* gene may be considered as a risk factor for insulin resistance but not the -420C \> T of *RETN* gene. The level of resistin is correlated with the insulin level in Indonesia.
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